The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1345, doi. 10.1007/s00262-007-0292-5
- By:
- Publication type:
- Article
Works matching AU Danielczyk, Antje
Results: 7
1
2
PankoMab: a potent new generation anti-tumour MUC1 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 11, p. 1337, doi. 10.1007/s00262-006-0135-9
- By:
- Publication type:
- Article
3
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01614
- By:
- Publication type:
- Article
4
Targeting a cancer-specific LYPD3 glycoform for tumor therapy.
- Published in:
- Frontiers in Drug Discovery, 2023, p. 1, doi. 10.3389/fddsv.2023.1298916
- By:
- Publication type:
- Article
5
Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
- Published in:
- Glycobiology, 2004, v. 14, n. 8, p. 681, doi. 10.1093/glycob/cwh090
- By:
- Publication type:
- Article
6
GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1406, doi. 10.3390/ijms25031406
- By:
- Publication type:
- Article
7
Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13697, doi. 10.3390/ijms232213697
- By:
- Publication type:
- Article